Bundle Sales Theronomic Flora Reshape Akkermansia Buy 3 Bottles Get Reds 10 Sachets Free

Product Overview

Theronomic Flora Reshape Akkermansia is positioned at the interface of gut microbiome science and precision metabolic health. Akkermansia muciniphila is a mucin-degrading, anaerobic bacterium that colonises the intestinal mucus layer, where it reinforces tight junction protein expression (including claudin-3 and occludin), reduces intestinal permeability ("leaky gut"), and produces short-chain fatty acids (SCFAs) and metabolites such as propionate that act on intestinal epithelial cells and enteroendocrine L-cells to stimulate GLP-1 secretion, improve insulin signalling, and modulate adipokine profiles. Its depletion — observed in metabolic syndrome, type 2 diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD) — is associated with increased endotoxaemia and systemic low-grade inflammation. Theronomic's formulation uses pasteurized (heat-inactivated) A. muciniphila, which preserves the bioactive outer membrane protein Amuc_1100 responsible for the majority of the bacterium's metabolic and barrier-protective effects.

Each bottle of Theronomic Flora Reshape Akkermansia is combined with Gold Kiwifruit powder (a prebiotic fibre source providing actinidin, vitamin C, and insoluble and soluble fibre to support digestive transit) and resistant potato starch (a type 2 resistant starch that escapes small intestinal digestion, reaching the colon where it serves as a selective prebiotic substrate for A. muciniphila and other beneficial taxa including Bifidobacterium and Faecalibacterium prausnitzii). The three-bottle bundle provides a full 90-day supplementation course, the minimum duration recommended in clinical trials examining changes in gut microbiome composition and metabolic markers. The free Reds sachets contain a polyphenol-rich botanical blend to provide complementary antioxidant support.

Product Specifications

Key Applications

• Metabolic syndrome and insulin resistance: Supports improved insulin sensitivity and reduced fasting insulinemia in overweight or obese adults; consistent with PMID 31263284 RCT findings on pasteurized A. muciniphila supplementation.
• Gut barrier restoration: Reinforces intestinal tight junction integrity, reducing mucosal permeability and systemic endotoxaemia associated with metabolic inflammation and dysbiosis.
• Weight management and body composition: Modulates satiety signalling through gut-brain axis (GLP-1 potentiation) and supports healthy body fat distribution as part of a structured dietary and lifestyle programme.
• Dysbiosis recovery and microbiome rebalancing: Replenishes depleted A. muciniphila populations following antibiotic courses, high-fat dietary patterns, or conditions associated with reduced mucosal bacterial diversity.
• Cholesterol and lipid management: Associated with modest reductions in total plasma cholesterol (−8.68% in clinical trial vs. placebo), complementing dietary and pharmacological lipid-lowering strategies.
• Extended 90-day gut health programme: The 3-bottle bundle supports the recommended minimum supplementation duration for measurable shifts in microbiome composition and host metabolic markers, with the Reds sachets providing complementary polyphenol antioxidant support.

Frequently Asked Questions

What distinguishes pasteurized Akkermansia muciniphila from conventional probiotic bacteria?

A. muciniphila is classified as a next-generation probiotic (NGP) and, in its pasteurized form, as a postbiotic — meaning it exerts its beneficial effects as a heat-inactivated, non-viable organism rather than as a live bacterial culture. Pasteurization preserves the outer membrane protein Amuc_1100, which is responsible for the majority of the metabolic and barrier-protective activity by binding to intestinal TLR2 receptors. This approach offers advantages in product stability, shelf life, and safety profile compared to live-culture probiotics, particularly for immunocompromised individuals. Conventional probiotic bacteria (e.g., Lactobacillus, Bifidobacterium) primarily support immune modulation and digestive health, whereas pasteurized A. muciniphila specifically targets mucin-layer homeostasis, metabolic regulation, and gut-liver-brain axis signalling.

Who is Theronomic Flora Reshape Akkermansia appropriate for, and are there any contraindications?

Flora Reshape Akkermansia is intended for adults aged 18 and above seeking to support metabolic health, gut barrier integrity, and microbiome diversity, particularly those with features of metabolic syndrome (central adiposity, elevated fasting glucose, dyslipidaemia, or hypertension) or those recovering from antibiotic-associated dysbiosis. It is suitable for individuals on lipid-lowering dietary programmes or as an adjunct to structured weight management. Individuals with active inflammatory bowel disease (IBD), Crohn's disease, or severely compromised immune function should consult a physician before commencing supplementation, as altered mucosal conditions may affect tolerability. A. muciniphila supplementation is not a replacement for prescribed metabolic medications; users on antidiabetic medications should monitor blood glucose and consult their physician if adjustments appear indicated.

Why is a 90-day course recommended, and what outcomes might be expected within that period?

Microbiome compositional changes are not immediate — measurable shifts in gut bacterial populations, tight junction protein expression, and circulating metabolic markers typically emerge over 4–12 weeks of consistent supplementation. The landmark Depommier et al. (2019) clinical trial observed significant improvements in insulin sensitivity and plasma cholesterol at 3 months of supplementation. A 90-day course with Theronomic Flora Reshape Akkermansia provides sufficient duration for A. muciniphila to re-establish mucosal colonisation, modulate host immune and metabolic signalling, and produce clinically meaningful changes in gut permeability markers (e.g., lipopolysaccharide-binding protein) and metabolic indices. Individual outcomes vary based on baseline microbiome composition, diet, and lifestyle factors.

How is this supplement regulated and quality-assured in Singapore?

As a health supplement sold in Singapore, Theronomic Flora Reshape Akkermansia is regulated under the Singapore Health Products Act (Cap. 122D) administered by the Health Sciences Authority (HSA). Health supplements are subject to HSA post-market surveillance and must comply with HSA requirements for labelling, prohibited ingredients, and permissible health claims. Pasteurized Akkermansia muciniphila has received Novel Food status approval from the European Food Safety Authority (EFSA), establishing its safety profile for human consumption in a regulatory jurisdiction with rigorous food safety standards. The product is manufactured under GMP conditions. Purchasers in Singapore should verify that the supplement label carries HSA-compliant information and contact EMIS for product documentation.